Nobel Prizes

Dear Research Advocate, Yesterday, the Senate passed a sweeping opioid package ( H.R. 6 ), previously passed by the House, and sent it to the President for his signature. It includes intensified research into new pain management therapies that factor importantly into a broad array of opioid response strategies. This can’t come too soon: according to a recent study from AHRQ, there were nearly 125,000 opioid-related hospitalizations among older Americans in 2015; more Americans died from drug overdoses in 2016 than the number of American lives lost -- 58,200 -- in the entirety of the Vietnam War. The opioid legislation is an excellent example of much needed bipartisanship; the FY19 Labor-H/...
Dear Research Advocate, The first presidential debate gave us little to go on regarding research for health. Americans are dying to know more ’€“ many, quite literally dying ’€“ about what either presidential candidate would do to speed up medical progress in the face of Alzheimer’€™s disease, Parkinson’€™s disease, ALS and the host of other disabling and deadly health threats that breed suffering, compromise independence and drive spiraling health care costs. Add to that the pivotal role medical innovation plays in our economy, and Americans absolutely deserve to know whether candidates will champion or shortchange it. All of us must say to candidates: Tell us what you will do, share your...

Sidebar Quote

Without continued support for health research, many of the most promising young scientists, their ideas and a myriad of potentially life-changing scientific breakthroughs will vanish into oblivion.
Paul Marinec, PhD; University of California San Francisco